Sponsor pipeline

Pell Bio-Med Technology Co., Ltd. clinical trial pipeline

2 active trials 1 recruiting 3 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Phase 1/2

Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Phase 1/2
NCT05326243	Phase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed…	Diffuse Large B Cell Lymphoma	Active, Not Recruiting	2026-10-09
Not specified
NCT05377307	Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy	Diffuse Large B Cell Lymphoma	Recruiting	2026-10-09

Get alerts when Pell Bio-Med Technology Co., Ltd.'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.